Refer a Patient to PeaceHealth Cancer Infusion Center in Vancouver or Longview
To our referring healthcare providers
We are happy to care for your patient! If you have questions, please call 360-514-2005.
If you are not a PeaceHealth Medical Group provider, the following elements are required before we can process your order and schedule your patient for treatment.
- Recent progress note from the ordering provider
- Relevant laboratory results and/or other supporting documentation
- Prior Authorization is required to be obtained and maintained by the ordering provider’s office
- Insurance documentation with the prior authorization letter or reference number
- Valid order (Please use the PeaceHealth-approved paper order)
Remember to include the following information when filling out a paper order:
- Select infusion center location
- Patient name AND date of birth
- Date of order issuance
- ICD-10 code AND Dx description
- Check the boxes of ALL orders you would like to activate
- Provider name (printed) at the bottom of each page of orders
- Provider signature AND date of signature at the bottom of each page of orders
- Name and contact information of the provider that will be following this patient (if different than the ordering provider)
- For blood products, contact the Infusion Intake Coordinator at 360-514-2005
- Completed PeaceHealth Infusion Order Form – with special attention to the “Provider Communication Orders”
Fax the order form to the location you are referring to:
St. John (Longview) Infusion Center
Fax: 360-501-0146
Southwest (Vancouver) Infusion Center
Fax: 360-514-1920
Referral Orders
- Abatacept (Orencia) Loading Dose Infusion (v. 07-10-24)
- Abatacept (Orencia) Maintenance Infusion (v. 07-10-24)
- ACTH Stimulation Test (v. 08-29-24)
- Agalsidase Beta (Fabrazyme) Infusion (v. 06-26-24)
- Belimumab (Benlysta) Initiation Infusion (v. 06-19-24)
- Belimumab (Benlysta) Maintenance Infusion (v. 06-15-24)
- Benralizumab (Fasenra) Injection (v. 05-24-24)
- Bezlotoxumab (Zinplava) Infusion (v. 06-19-24)
- Blood Products Transfusion (v. 06-15-24)
- Cefepime Infusion (v. 08-29-24)
- Ceftriaxone Infusion (v. 08-29-24)
- Cyanocobalamine (Vitamin B-12) Monthly Injection (v. 05-24-24)
- Dalbavancin (Dalvance) Infusion (v. 06-15-24)
- Daptomycin Infusion (v. 09-12-24)
- Denosumab (Prolia) Injection (v. 05-16-24)
- Efgartigimod ALFA-FCAB (Vyvgart) Infusion (v. 09-12-24)
- Eptinezumab (Vyepti) Infusion (v. 06-15-24)
- Ertapenem Infusion (v. 08-29-24)
- Golimumab (Simponi Aria) Initiation Infusion (v. 07-10-24)
- Golimumab (Simponi Aria) Maintenance Infusion (v. 07-10-24)
- Hydration Prior To & After Contrast for Renal Failure (v. 06-19-24)
- Hydration Therapy Plan (v. 06-19-24)
- Ibandronate (Boniva) Infusion (v. 05-24-24)
- Immune Globulin (IVIG) Infusion (v. 05-24-24)
- Infliximab Or Biosimilars Initiation Infusion (v. 07-10-24)
- Infliximab Or Biosimilars Maintenance Infusion (v. 07-10-24)
- Iron - Ferric Carboxymaltose (Injectafer) Infusion (v. 05-24-24)
- Iron - Ferric Derisomaltose (Monoferric) Infusion (v. 06-19-24)
- Iron - Iron Sucrose (Venofer) Infusion (v. 05-24-24)
- Lanreotide (Somatuline Depot) Injection (v. 05-24-24)
- Leuprolide (Lupron) Breast & Gynecology Injection (v. 06-19-24)
- Leuprolide (Lupron) Prostate Injection (v. 06-19-24)
- Line Care Therapy Plan (v. 05-24-24)
- Mepolizumab (Nucala) Injection (v. 05-24-24)
- Methylprednisolone Infusion (v. 06-19-24)
- Natalizumab (Tysabri) Infusion (v. 08-29-24)
- Ocrelizumab (Ocrevus) Infusion (v. 07-10-24)
- Octreotide Acetate (SANDOSTATIN) Monthly Injection (v. 06-19-24)
- Omaluzimab (Xolair) Injection (v. 05-24-24)
- Pegloticase (Krystexxa) Infusion (v. 09-12-24)
- Penicillin Infusion (v. 08-29-24)
- Reslizumab (Cinqair) Infusion (v. 06-19-24)
- Risankizumab-RZAA (Skyrizi) Infusion (v. 09-12-24)
- Rituximab Or Biosimilar Infusion (v. 07-10-24)
- Romosozumab-AQQG (Evenity) Monthly Injection (v. 08-29-24)
- Tezepelumab EKKO (TEZSPIRE) Injection (v. 05-28-24)
- Therapeutic Phlebotomy (v. 06-19-24)
- Thyrotropin Alfa (Thyrogen) Injection (v. 06-26-24)
- Toclizumab (Actemra) Infusion (v. 06-21-24)
- Ustekinumab (Stelara) Infusion (v. 07-10-24)
- Vedolizumab (Entyvio) Initiation Infusion (v. 07-11-24)
- Vedolizumab (Entyvio) Maintenance Infusion (v. 07-11-24)
- Zoledronic Acid (Reclast) Infusion (v. 05-16-24)